Showing results 301-320 / 483
Larry Pentz to Retire from the Board of Johnson Matthey
After a long and distinguished career, Larry Pentz will retire as an executive director of the company on 31st March 2016
ExploreMichael Roney to Retire from Board
Michael Roney, a non-executive director, Senior Independent Director and Chairman of the Management Development and Remuneration Committee, has decided to retire from the board in July 2014 having served as a non-executive director for seven years.
ExploreJohnson Matthey Plc announces Patrick Thomas as Chairman Designate
News: The Board of Directors of Johnson Matthey Plc is pleased to announce that Patrick Thomas will succeed Tim Stevenson as Chairman.
ExploreJohnson Matthey is Britain's Most Admired Chemicals Company
JM beat off competition from Croda and Victrex to keep the Chemicals title and is 5th most admired overall
ExplorePartnering with GreenCentre Canada
News: We've announced the successful scale-up and commercial availability of a novel Gusev catalyst for ester hydrogenation.
ExploreJohnson Matthey sells Gold and Silver Refining business for £118 million
Johnson Matthey sells Gold and Silver Refining business for £118 million
ExploreJohnson Matthey acquires pharmaceutical manufacturing capacity in Scotland, UK
The 109,000 square metre site will help meet increasing demand for custom pharmaceutical services and active ingredients using enhanced manufacturing capabilities
ExploreUK Business Secretary receives Johnson Matthey India's 25 millionth autocatalyst
UK Business Secretary receives Johnson Matthey India's 25 millionth autocatalyst
ExploreJohnson Matthey Chemist Wins Prestigious Royal Society of Chemistry Prize
Johnson Matthey Chemist Wins Prestigious Royal Society of Chemistry Prize
ExploreJohnson Matthey wins corporate reporting award
Johnson Matthey has been awarded ‘Best Sustainability and Stakeholder Disclosure in the FTSE 100’ by the Institute of Chartered Secretaries and Administrators
ExploreJM and bp technology turning waste into sustainable fuels scoops top prize
News: bp-JM Fischer-Tropsch technology wins RSC's 2021 Dalton Division Horizon Prize
ExploreJohnson Matthey appoints Jane Griffiths as Non-Executive Director
Jane has significant experience in the pharmaceutical sector and will join the board on 1st January 2017
Explore
JM and Rennovia announce licence agreement with ADM for glucaric acid production technology
News: We have signed a licence agreement with Archer Daniels Midland Company alongside Rennovia Inc. for glucaric acid production technology.
ExploreJohnson Matthey Agrees Sale of Research Chemicals Business (Alfa Aesar) for £256 million
Johnson Matthey announces that it has agreed to divest its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific Inc., the world leader in serving science, for £256 million
ExploreDen Jones to Succeed Robert MacLeod as Group Finance Director of Johnson Matthey
Following the recent announcement that Robert MacLeod will succeed Neil Carson as Chief Executive of Johnson Matthey, we are pleased to announce that Den Jones will join the board of Johnson Matthey on 5th June 2014, succeeding Robert as Group Finance Director.
Explore
